The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)

Status unconfirmed · Phase 2 · Has a placebo group

Conditions studied: Age-Related Macular Degeneration

In brief

The purpose of this trial is to compare the ability of two doses of OT-551 ophthalmic solution and drug-free solution to safely and effectively treat geographic atrophy associated with age-related macular degeneration.

Key facts

Study ID
NCT00485394
Run by
Othera Pharmaceuticals
People needed
198
Starts
2007-06-01
Last updated by the study team
2008-04-02

Who can join

Age: 55 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.